(May 5): Shares of Star Sports Medicine Co, a maker of medical devices, surged as much as 204% in their Hong Kong trading debut on Tuesday, extending a run of hot first-day performances in the city.
The stock climbed to as high as HK$299 early trading, compared with an initial public offering price of HK$98.50 per share. Strong investor demand helped the company raise HK$829.6 million, with its retail portion subscribed more than 7,823 times.
The debut adds to a string of strong Hong Kong listings in recent months, as investors warm to Chinese healthcare and technology names. The weighted average first-day gain of listings that raised at least US$100 million has been 42.3% this year, according to data compiled by Bloomberg. Recent debuts included a roughly 380% pop for optical-computing firm Lightelligence and a 241% surge for hardware and software firm Shanghai Sunmi Technology.
Demand for medical devices has been rising across China’s ageing and increasingly active population, drawing a wave of listings from domestic equipment makers and innovative drugmakers to Hong Kong.
Star Sports is a Beijing-based medical device maker specialising in clinical sports medicine solutions targeting major joints. Its product portfolio spans self-developed implants, equipment, consumables and surgical instruments used for injury treatment, rehabilitation and prevention.
See also: Jack Ma-backed Ant’s profit falls 79% on AI, healthcare costs
Uploaded by Arion Yeow
